Coexistence of Tumor-Induced Osteomalacia and Primary Hyperparathyroidism-Reference-Cited by-同舟云学术

Coexistence of Tumor-Induced Osteomalacia and Primary Hyperparathyroidism

Published:2011-11 Issue:6 Volume:17 Page:144-148
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Markou Athina,Tsiama Vassiliki,Tournis Symeon,Papanastasiou Labrini,Tsiavos Vaios,Dassou Aikaterini,Vlachou Vasiliki,Papaliodi Eugenia,Asimaki Niki,Zografos George,Piaditis George

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://aace.metapress.com/index/A5J325271068T28R.pdf

Reference20 articles.

1. Tumor-induced osteomalacia;Chong;Endocr Relat Cancer,2011

2. Tumor-induced osteomalacia;Jan de Beur;JAMA,2005

3. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report;Tartaglia;G Chir,2006

4. Autonomous hyperparathyroidism following long-term phosphate treatment for tumor-induced osteomalacia. Case report and review of the literature;Tournis;The Endocrinologist,2007

5. Osteomalacia secondary to osteosarcoma. A case report;Cheng;J Bone Joint Surg Am,1989

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rare combination of tumor-induced osteomalacia caused by sinonasal glomangiopericytoma and coexisting parathyroid adenoma: case report and literature review;BMC Endocrine Disorders;2022-01-28

2. Coexistence of cutaneous phosphaturic mesenchymal tumour and postoperative hypoparathyroidism;European Journal of Dermatology;2016-05

3. Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors;Endocrinology, Diabetes & Metabolism Case Reports;2015-07-01

4. Cinacalcet for Management of Tertiary Hyperparathyroidism Associated with Chronic Treatment of Hypophosphatemia in an Adult with Tumor-Induced Osteomalacia;AACE Clinical Case Reports;2015

5. Tumor(s) Induced Osteomalacia—A Curious Case of Double Trouble;The Journal of Clinical Endocrinology & Metabolism;2014-02-01